Keyphrases
Anthracyclines
100%
Cardiovascular Toxicity
100%
Statins
87%
Myocardial Injury
42%
Left Ventricular Dysfunction
42%
Primary Prevention
42%
Magnetic Resonance Imaging
37%
Women with Breast Cancer
28%
Clinical Trials
25%
Breast Cancer
25%
NHLBI
25%
Adjuvant Therapy
14%
Myalgia
14%
Community Oncology
14%
Statin Therapy
14%
Creatine Kinase Elevation
14%
Coenzyme A
14%
South Florida
14%
Innovative Form
14%
Readability
14%
Negative Breast Cancer
14%
Long-term Survival
14%
Cardiotoxicity
14%
Cardiovascular Injury
14%
Left Ventricular Function
14%
Atorvastatin
14%
Permuted Block
14%
Causes of Mortality
14%
Randomized Placebo-controlled Trial
14%
Forest Research
14%
Cardiovascular Abnormalities
14%
Reductase Inhibitors
14%
Serum Biomarkers
14%
Breast Cancer Patients
14%
Cardiac Dysfunction
14%
3-hydroxy-3-methylglutaryl-CoA Reductase
14%
Progesterone
12%
Heart Failure Patients
12%
Human Epidermal Growth Factor Receptor 2 (HER2)
12%
Cardiovascular Disease
12%
South Carolina
12%
Cognitive Decline
12%
Clinical Community
12%
Imaging Biomarkers
12%
Diabetes
12%
National Cancer Institute
12%
Triple-negative Breast Cancer
12%
Heart Failure
12%
Estrogen
12%
Patients with Cancer
12%
Triple Negative
12%
Randomized Clinical Trial
12%
Cardiovascular Events
12%
North Carolina
12%
Medicine and Dentistry
Anthracycline
100%
Cardiovascular Toxicity
100%
Statin
87%
Chemotherapy
75%
Breast Cancer
75%
Primary Prevention
42%
Heart Left Ventricle Failure
42%
Heart Muscle Injury
42%
Magnetic Resonance Imaging
37%
Cardiovascular System
25%
Clinical Trial
25%
Heart Failure
25%
Adjuvant Therapy
14%
HMG-CoA
14%
Heart Left Ventricle Function
14%
Atorvastatin
14%
Cardiovascular Malformation
14%
Myalgia
14%
Epidermal Growth Factor Receptor 2
14%
Creatine Kinase
14%
Cardiotoxicity
14%
Cardiovascular Injury
14%
Triple Negative Breast Cancer
14%
Oxidoreductase
14%
Long Term Survival
14%
Cardiovascular Disease
12%
Randomized Clinical Trial
12%
Side Effect
12%
Progesterone
12%
Biological Marker
12%
Base
12%
Patient Referral
12%
Placebo
12%
Diabetes
12%
Health Care Cost
12%
Oncology
12%
Malignant Neoplasm
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cardiovascular Toxicity
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
100%
Anthracycline
100%
Breast Cancer
75%
Heart Muscle Injury
42%
Heart Left Ventricle Failure
42%
Malignant Neoplasm
25%
Heart Failure
25%
Clinical Trial
25%
Creatine Kinase
14%
Myalgia
14%
HMG-CoA
14%
Atorvastatin
14%
Long Term Survival
14%
Triple Negative Breast Cancer
14%
Statin (Protein)
14%
Epidermal Growth Factor Receptor 2
14%
Cardiotoxicity
14%
Cardiovascular Malformation
14%
Randomized Clinical Trial
12%
Base
12%
Injury
12%
Biological Marker
12%
Oxidoreductase
12%
Placebo
12%
Cardiovascular Disease
12%
Side Effect
12%
Progesterone
12%